Return to List

Study Summary
No. GOG 0206:.......Gynecology......Charles Levenback......Gynecologic Oncology
.
Study Summary Title
Study Summary
Number:		GOG 0206
Study Title:Lymphatic Mapping and Sentinel Node Identification in Patients with Stage 1B1 Cervical Carcinoma
.
Physician New Patient Referral
Name:Charles LevenbackPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Gynecologic OncologyReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-745-2563
Contact us about clinical trials
.
General Information
Disease Group:GynecologySupported By:Gynecologic Oncology Group
Phase of Study:N/AReturn
Visit:		Routine post-operative follow-up
Treatment
Agents:		Treatment information not availableHome Care:N/A
Treatment Loc:both inpatient and outpatient
Estimated
Length of Stay
in Houston:		5-7 days (post operative recovery period for radical hysterectomy)
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:11/29/2004
IRB Review and Approval Date:08/18/2004
Study Type:Not Applicable
Recruitment Status:Open
Projected Accrual:36
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:Patients with stage IB1 (less than or equal to 4 cm) carcinoma of the cervix, squamous carcinoma, adenocarcinoma, or adenosquamous carcinoma. A previous cone biopsy is acceptable as long as the patient is stage IB1.

Patients must be good surgical candidates.

Patients who have met the pre-entry requirements specified in protocol section 7.0.

Patients who have signed an approved informed consent and authorization permitting release of personal health information.

If computed tomography, magnetic resonance imaging, lymphangiography or ultrasound has been performed for preoperative assessment, there must be no evidence of metastases. Imaging is not mandatory.
Exclusion Criteria:Patients with known allergies to triphenylmethane compounds.

Patients with a history of retroperitonel surgery.

Patients with a history of pelvic irradiation.

Patients who had a cold knife or LEEP cone biopsy within 4 weeks of enrollment.
.
Links
Registration Number: NCT00070317
Study Information on Clinical Trials Registry (clinicaltrials.gov)
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center